Solvemed

Digitized Ocular Biomarker for Neurological Disease Diagnosis

Solvemed

Digital Biomarker

|

Cambridge, UK

About

Solvemed develops a digitized ocular biomarker for neurological disease diagnosis. Using a smartphone-based pupil light reflex exam and proprietary analytics, its technology supports earlier detection and monitoring of disorders such as Parkinson's disease.

Co-Investors

ATMOS Ventures, Sunfish Partners

Copyright 2026
APEX Ventures GmbH

Sitemap

Copyright 2026
APEX Ventures GmbH

Sitemap

Copyright 2026
APEX Ventures GmbH

Sitemap